Vialis acquired by Accelrys

Please login or
register
30.01.2013
Accelrys Inc., a leading provider of scientific innovation lifecycle management software, is solidifying its market leadership in the laboratory informatics space with the acquisition of its long-time partner Vialis AG, a leading systems integrator based in Liestal. Accelrys has purchased all of Vialis’ outstanding stock for approximately $5 million in cash. The acquisition includes potential for additional incentive consideration of up to approximately $5 million in cash.

Vialis, founded in 2006 and based in Liestal, is a systems integrator serving the pharmaceutical, biotechnology, chemicals, and agro-science industries. Vialis’ deep experience implementing and supporting paperless laboratory solutions further strengthens Accelrys’ position in the laboratory informatics software market and expands the company’s capabilities in the downstream analytical development, quality control, and quality assurance and manufacturing areas.
 
In addition to its systems integration services, Vialis’ business process consultancy delivers process improvements in lab data management. Employing a proprietary approach to analyzing existing lab processes, Vialis’ business process consultancy services help customers optimize efficiency, enhance quality by design eff orts, increase compliance, maximize knowledge reuse and reduce cycle times.
 
Under terms of the deal, Accelrys has purchased all of Vialis’ outstanding stock for approximately $5 million in cash. The acquisition includes potential for additional incentive consideration of up to approximately $5 million in cash, contingent upon meeting specified growth objectives over the next three years.
 
The entire Vialis team is joining Accelrys. “As a long-standing partner, we share Accelrys’ vision of transforming the innovation lifecycle by delivering paperless laboratory solutions that enhance our customers’ abilities to meet the operational challenges that are slowing scientific innovation,” said Vialis CEO Ulf Fuchslueger, PhD. “Importantly, we share closely aligned go-to-market approaches and we believe this transition will bring significant leverage to our customers and partners.”
 
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientifi c innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. Accelrys solutions are used by more than 1,300 companies in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, California, USA, Accelrys employs more than 200 full-time PhD scientists.

0Comments

rss